The German supplier of human dura mater blamed for a number of cases of the fatal Creutzfeldt-Jakob disease in Japan plans to reach a negotiated settlement on suits filed by patients and victims’ families, the company said in a statement Wednesday.

B. Braun Melsungen AG said in the statement, “For an early resolution, we will present a settlement proposal tomorrow to the Tokyo and Otsu district courts that will include specific figures and conditions,” although it does not agree to several key disputed points in the suits.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.